MedTrace Logo

Microcurrent for Healing Autogenous Skin Donor Sites

NCT00558701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-06-06

Study results available
· View outcomes & findings →

Summary

This single-center, prospective, randomized, and controlled study evaluated the efficacy of silver-coated dressing with active microcurrent in comparison to silver-coated dressing with sham microcurrent on wound-closure time for autogenous skin donor sites.

Conditions

  • Burns

Interventions

DEVICE

Microcurrent stimulator

Microcurrent stimulation from 15-50 microamps

DEVICE

Silverlon Wound Contact Dressing

Silver coated nylon dressing FDA approved for use on donor sites in burn patients

Sponsors & Collaborators

  • Samueli Institute for Information Biology

    collaborator OTHER

  • United States Army Institute of Surgical Research

    lead FED

Principal Investigators

  • Leopoldo C Cancio, MD · United States Army Institute of Surgical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00558701 on ClinicalTrials.gov